Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bridge Pharma IncfiledCriticalBridge Pharma Inc
Priority to MYPI20015099priorityCriticalpatent/MY130184A/en
Publication of MY130184ApublicationCriticalpatent/MY130184A/en
THE PRESENT INVENTION RELATES TO NEW AMINOINDANE PIPERIDINE COMPOUNDS, THE METHOD OF USING AMINOINDANE COMPOUNDS AS LOCAL ANESTHETICS, SAID COMPOUND HAVING PARTICULARLY VALUABLE PROPERTIES AS DERMAL AND TOPICAL ANESTHETICAL MAN, AS WELL AS COMPOSITIONS CONTAINING SAID COMPOUNDS.
Novel compound of 6-methyl-3-phenethyl-3,4-dihydro-1H-quinazoline-2-thione, its preparation and a depigmentation composition containing the same as an effective component